Mary Kosinski joined the firm as global managing director for the sector, along with other leadership additions.
FleishmanHillard Expands Health and Life Sciences Global Leadership Team
You May Also Like
Global Launch Strategies in the Current Political Climate
February 19, 2025
FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk
February 19, 2025
Navigating Distrust: Pharma in the Age of Social Media
February 18, 2025
+ There are no comments
Add yours